Back to Superinvestors
SUPERINVESTOR HOLDERS
GILD
Gilead Sciences Inc
Healthcare · Drug Manufacturers - General
- Holders
- 7
- Total value
- $3,292,352,046
- Total shares
- 26,066,779
- Cross-link
- Financials →
| Investor | Shares | Value | % of Portfolio | Activity | As of |
|---|---|---|---|---|---|
|
Dodge & Cox
Dodge & Cox
|
23,677,567 | $2,991,423,815 | 1.57% | REDUCE -573,259 | 30 Jun 2026 |
|
Hersh Cohen
ClearBridge Investments
|
1,088,957 | $137,578,823 | 0.11% | REDUCE -142,193 | 30 Jun 2026 |
|
Cliff Asness
AQR Capital Management
|
695,432 | $86,936,071 | 0.03% | REDUCE -469,371 | 30 Jun 2026 |
|
Joel Greenblatt
Gotham Asset Management
|
381,851 | $48,243,055 | 0.11% | ADD +6,007 | 30 Jun 2026 |
|
John Rogers
Ariel Investments
|
195,657 | $24,719,305 | 0.25% | REDUCE -6,614 | 30 Jun 2026 |
|
Ron Baron
Baron Capital (BAMCO)
|
18,000 | $2,274,120 | 0.00% | REDUCE -12,000 | 30 Jun 2026 |
|
Eric Marshall
Hodges Capital Management
|
9,315 | $1,176,857 | 0.08% | ADD +597 | 30 Jun 2026 |